Indian pharma industry estimated to grow 9 to 11 percent in FY22: ICRA Medical Dialogues Bureau5 Jan 2022 9:15 AM IST"Revenue growth for ICRA sample set is estimated at 9 to 11 per cent in FY2022 and in FY2023, supported by gradual recovery post the impact of COVID,"...
Pfizer to supply more 10 million courses of COVID pills to US Medical Dialogues Bureau5 Jan 2022 9:00 AM IST"These pills will be delivered in the coming months and have been shown to dramatically decrease hospitalization and death from COVID19," the White...
Pfizer COVID booster shot for 12 to 15-year-olds backed by USFDA Medical Dialogues Bureau4 Jan 2022 9:45 AM ISTThe regulatory decisions come as COVID cases surge due to the Omicron variant, with health authorities warning that its high transmissibility could...
Interval between Moderna COVID vaccine 2nd shot, booster still 6 months: USFDA Medical Dialogues Bureau4 Jan 2022 9:30 AM ISTWashington: The interval between receiving a second dose of Moderna's COVID-19 vaccine and a booster dose remains unchanged at six months, U.S. Food...
Alembic Pharma Doxycycline Hyclate Delayed-Release Tablets get USFDA okay Medical Dialogues Bureau4 Jan 2022 9:30 AM ISTThe approved Doxycycline Hyclate delayed release tablets are therapeutically equivalent to the reference listed drug product (RLD) Doryx Tablets, 75...
Piramal Pharma Solutions expands in vitro biology capabilities Medical Dialogues Bureau4 Jan 2022 9:15 AM ISTThis new expansion, which is expected to go live in Q3 2022, will significantly add to the primary and secondary screening capabilities of compounds...
Noida to get 350-acre medical device park Medical Dialogues Bureau4 Jan 2022 9:00 AM ISTThe medical device park would focus on industrial development of CT scans, MRI and ventilators, YEIDA CEO Arun Vir Singh said.
Natco Pharma acquires Dash Pharma Ruchika Sharma3 Jan 2022 11:50 AM ISTNew Delhi: Natco Pharma Inc. USA, a wholly owned subsidiary of NATCO Pharma Limited , has completed the acquisition of Dash Pharmaceuticals LLC, a...
Xeris Biopharma gets USFDA approval for Endogenous Hypercortisolemia drug Recorlev Ruchika Sharma3 Jan 2022 11:00 AM ISTChicagoXeris Biopharma Holdings, Inc. has announced the U.S. Food and Drug Administration (FDA) approval of Recorlev (levoketoconazole) for the...
Boosters increase vaccine efficacy against Omicron by 88 percent, claims study MD Bureau3 Jan 2022 10:30 AM ISTLondon: Although the Omicron variant of Covid has been shown to evade vaccines, two new studies led by the UK health agency showed that a third...
More Covaxin doses supplied to Afghanistan: Bharat Biotech Ruchika Sharma3 Jan 2022 10:00 AM ISTNew Delhi: Bharat Biotech on Monday informed that India has supplied another batch of humanitarian assistance consisting of 5,00,000 doses of COVID-19...
Belgium to buy courses of Pfizer, Merck COVID pills Ruchika Sharma3 Jan 2022 9:00 AM ISTBrussels: Belgium has agreed to buy 10,000 courses each of the COVID-19 antiviral oral treatments developed by Pfizer and Merck & CO, a...
